News

Feb 1, 2024
Basking Biosciences Announces Close of $55 Million Financing to Accelerate Clinical Development for First Reversible Thrombolytic for Ischemic Stroke
Read More
Jan 25, 2024
CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study
Read More
Jan 17, 2024
Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia
Read More
Dec 13, 2023
Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
Read More
Sep 26, 2023
Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
Read More
Sep 26, 2023
Cardiosense Begins Enrollment in Nationwide Heart Failure Study
Read More